Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry.

Henriksen EKK, Viken MK, Wittig M, Holm K, Folseraas T, Mucha S, Melum E, Hov JR, Lazaridis KN, Juran BD, Chazouillères O, Färkkilä M, Gotthardt DN, Invernizzi P, Carbone M, Hirschfield GM, Rushbrook SM, Goode E; UK-PSC Consortium, Ponsioen CY, Weersma RK, Eksteen B, Yimam KK, Gordon SC, Goldberg D, Yu L, Bowlus CL, Franke A, Lie BA, Karlsen TH.

HLA. 2017 Oct;90(4):228-233. doi: 10.1111/tan.13076. Epub 2017 Jul 11.

PMID:
28695657
2.

MHC Class II alleles in ulcerative colitis-associated colorectal cancer.

Garrity-Park MM, Loftus EV Jr, Sandborn WJ, Bryant SC, Smyrk TC.

Gut. 2009 Sep;58(9):1226-33. doi: 10.1136/gut.2008.166686. Epub 2009 Feb 26.

PMID:
19251712
3.

Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation.

Rubio-Tapia A, Abdulkarim AS, Wiesner RH, Moore SB, Krause PK, Murray JA.

Liver Int. 2008 Apr;28(4):467-76. doi: 10.1111/j.1478-3231.2008.01681.x.

4.

Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.

Cholongitas E, Papatheodoridis GV, Zappoli P, Giannakopoulos A, Patch D, Marelli L, Shusang V, Kalambokis G, Shirling G, Rolando N, Burroughs AK.

Liver Transpl. 2007 Apr;13(4):552-7.

5.

Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.

Karlsen TH, Boberg KM, Vatn M, Bergquist A, Hampe J, Schrumpf E, Thorsby E, Schreiber S, Lie BA; IBSEN Study Group.

Genes Immun. 2007 Apr;8(3):275-8. Epub 2007 Feb 15.

PMID:
17301827
6.

Primary sclerosing cholangitis in two brothers: report of a family with special emphasis on molecular HLA and MICA genotyping.

Van Steenbergen W, De Goede E, Emonds MP, Reinders J, Tilanus M, Fevery J.

Eur J Gastroenterol Hepatol. 2005 Jul;17(7):767-71.

PMID:
15947556
7.

Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population.

Neri TM, Cavestro GM, Seghini P, Zanelli PF, Zanetti A, Savi M, Podda M, Zuin M, Colombo M, Floreani A, Rosina F, Bianchi Porro G, Strazzabosco M, Okolicsanyi L.

Dig Liver Dis. 2003 Aug;35(8):571-6.

PMID:
14567462
8.
9.

Association of primary sclerosing cholangitis, ulcerative colitis and coeliac disease in female siblings.

Habior A, Rawa T, Orłowska J, Sankowska M, Lewartowska A, Tilszer A, Pawlak J, Krawczyk M, Butruk E.

Eur J Gastroenterol Hepatol. 2002 Jul;14(7):787-91.

PMID:
12169991
10.

Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure.

Kaukinen K, Halme L, Collin P, Färkkilä M, Mäki M, Vehmanen P, Partanen J, Höckerstedt K.

Gastroenterology. 2002 Apr;122(4):881-8.

PMID:
11910339
11.

A patient with hereditary hemochromatosis, ulcerative colitis, and primary sclerosing cholangitis: genetic aspects.

Ponsioen CY, Stokkers PC, vd Horst AR, Tytgat GN, van Deventer SJ.

Eur J Intern Med. 2001 Dec;12(6):518-21.

PMID:
11711276
12.

The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.

Boberg KM, Spurkland A, Rocca G, Egeland T, Saarinen S, Mitchell S, Broomé U, Chapman R, Olerup O, Pares A, Rosina F, Schrumpf E.

Scand J Gastroenterol. 2001 Aug;36(8):886-90.

PMID:
11495087
13.

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.

Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broome U, Caballeria L, Ciusani E, Chapman R, Ercilla G, Fausa O, Knutsen I, Pares A, Rosina F, Olerup O, Thorsby E, Schrumpf E.

Tissue Antigens. 1999 May;53(5):459-69.

PMID:
10372541
14.

Sclerosing cholangitis, race and sex.

Kelly P, Patchett S, McCloskey D, Alstead E, Farthing M, Fairclough P.

Gut. 1997 Nov;41(5):688-9.

15.

HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.

Underhill JA, Donaldson PT, Doherty DG, Manabe K, Williams R.

Hepatology. 1995 Apr;21(4):959-62.

PMID:
7705806
16.

Does HLA status influence prognosis in primary sclerosing cholangitis?

Chapman R.

Gastroenterology. 1995 Mar;108(3):937-40. No abstract available.

PMID:
7875501
17.

HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis.

Olerup O, Olsson R, Hultcrantz R, Broome U.

Gastroenterology. 1995 Mar;108(3):870-8.

PMID:
7875491
18.

HLA-DR3, DQ2 homozygosity in two patients with insulin-dependent diabetes mellitus superimposed with ulcerative colitis and primary sclerosing cholangitis.

Ivarsson SA, Eriksson S, Kockum I, Lernmark A, Lindgren S, Nilsson KO, Sundkvist G, Wassmuth R.

J Intern Med. 1993 Mar;233(3):281-6.

PMID:
8450297
19.

Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis.

Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar KM, Welsh KI, Eddleston AL, Williams R.

Hepatology. 1992 Aug;16(2):390-5.

PMID:
1639348

Supplemental Content

Loading ...
Support Center